Originally a women-oriented virtual online health center, Flo launches a line of helpful micronutrient support for hormone balance — from the pain-relieving omega oil blend and the mood-boosting coenzymated B complex to the free radical-combating detoxification supplement and the cortisol-regulating buffered chelated magnesium.
The products are non-GMO, free from synthetics, colorants, gluten and allergens. The harmonizing omega oil blend, for one, contains vitamins D, K1 and K2. Not only does the supplement help women deal with mood swings, it also reduces prostaglandins — which are known to cause cramping, as well as it minimizes oxidative stress and inflammation.
The fish oil, contained in Flo's product is "molecularly distilled and filtered to ensure purity," as well as the removal of heavy metals, pesticides and other harmful contaminants.
What's Driving This Trend
- Hormone Balancing Supplements
- The launch of Flo's line of micronutrient support for hormone balance presents an opportunity for disruptive innovation in the health and wellness industry.
- Natural and Non-gmo Products
- The popularity of Flo's non-GMO, synthetic-free, and allergen-free products reflects the growing demand for natural and clean-label products, opening up opportunities for disruptive innovation in the food and supplement industry.
- Anti-inflammatory and Pain-relieving Solutions
- Flo's harmonizing omega oil blend, which reduces cramping and inflammation, highlights the potential for disruptive innovation in the pain relief and anti-inflammatory sector.
Who This Affects Most
- Health and Wellness
- The launch of Flo's hormone balancing supplements presents disruptive innovation opportunities in the health and wellness industry.
- Food and Beverage
- The demand for natural and non-GMO products creates opportunities for disruptive innovation in the food and beverage industry.
- Pharmaceuticals
- The development of anti-inflammatory and pain-relieving solutions, such as Flo's harmonizing omega oil blend, opens up opportunities for disruptive innovation in the pharmaceutical industry.
